Monday, 06 July 2020

Lupin launches generic version of Apriso

19 May 2020 | News

It is indicated for the maintenance of remission of ulcerative colitis in patients 18 years of age and older

Source: Shutterstock

Source: Shutterstock

Lupin has announced the launch of authorized generic version of Bausch Health’s Apriso® (Mesalamine Extended-Release Capsules 0.375 g) in the U.S.

Mesalamine Extended-Release Capsules 0.375 g (authorized generic version) are indicated for the maintenance of remission of ulcerative colitis in patients 18 years of age and older.

Mesalamine Extended-Release Capsules 0.375 g, RLD: Apriso® had an annual sales of approximately USD 290 million in the U.S. (IQVIA MAT March 2020).

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account